HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Enzyme-catalyzed therapeutic agent (ECTA) design: activation of the antitumor ECTA compound NB1011 by thymidylate synthase.

Abstract
The in vivo administration of enzyme-inhibiting drugs for cancer and infectious disease often results in overexpression of the targeted enzyme. We have developed an enzyme-catalyzed therapeutic agent (ECTA) approach in which an enzyme overexpressed within the resistant cells is recruited as an intracellular catalyst for converting a relatively non-toxic substrate to a toxic product. We have investigated the potential of the ECTA approach to circumvent the thymidylate synthase (TS) overexpression-based resistance of tumor cells to conventional fluoropyrimidine [i.e. 5-fluorouracil (5-FU)] cancer chemotherapy. (E)-5-(2-Bromovinyl)-2'-deoxy-5'-uridyl phenyl L-methoxyalaninylphosphoramidate (NB1011) is a pronucleotide analogue of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVdU), an antiviral agent known to be a substrate for TS when in the 5'-monophosphorylated form. NB1011 was synthesized and found to be at least 10-fold more cytotoxic to 5-FU-resistant, TS-overexpressing colorectal tumor cells than to normal cells. This finding demonstrates that the ECTA approach to the design of novel chemotherapeutics results in compounds that are selectively cytotoxic to tumor cell lines that overexpress the target enzyme, TS, and therefore may be useful in the treatment of fluoropyrimidine-resistant cancer.
AuthorsD B Lackey, M P Groziak, M Sergeeva, M Beryt, C Boyer, R M Stroud, P Sayre, J W Park, P Johnston, D Slamon, H M Shepard, M Pegram
JournalBiochemical pharmacology (Biochem Pharmacol) Vol. 61 Issue 2 Pg. 179-89 (Jan 15 2001) ISSN: 0006-2952 [Print] England
PMID11163332 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • Deoxyuracil Nucleotides
  • NB1011
  • Prodrugs
  • brivudine
  • 2'-deoxyuridylic acid
  • Thymidylate Synthase
  • Bromodeoxyuridine
Topics
  • Animals
  • Antineoplastic Agents (administration & dosage, metabolism, pharmacology)
  • Bromodeoxyuridine (administration & dosage, analogs & derivatives, metabolism, pharmacology)
  • Deoxyuracil Nucleotides (chemistry, metabolism)
  • Disease Models, Animal
  • Drug Design
  • Drug Screening Assays, Antitumor
  • Humans
  • Mice
  • Mice, Nude
  • Prodrugs (administration & dosage, metabolism, pharmacology)
  • Thymidylate Synthase (administration & dosage, metabolism)
  • Tumor Cells, Cultured
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: